Skip to main content

Table 1 Individual patient anthracycline dosage, time to first diagnosis and fractional shortening percentage

From: Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy

Individual Druga Cumulative Dose
(mg/m2)
FS %b Time (days) to initial abnormal echo.c
1 Daun 435 14 276
2 Daun, Mitox 410 23.3 145
3 Dox 356 22.9 267
4 Daun, Dox 325 6 1343
5 Dox 260 23.9 81
6 Dox 255 23.1 64
7 Daun 204 19.7 71
8 Daun 200 21.5 26
9 Daun, Dox 178 23 1805
10 Daun, Dox 175 23.5 253
11 Daun, Ida 161 23.9 17
12 Daun, Dox 147 20.5 1151
13 Daun, Dox 136 19.9 88
14 Dox 72 23.3 214
15 Dox 51 23.9 106
  1. aDaun daunorubicin; Dox doxorubin; Mitox mitroxantrone; Ida Idarubicin. b most abnormal record of fractional shortening. cecho echocardiography